[Des-Arg9]-Bradykinin acetate

[Des-Arg9]-Bradykinin acetate is a synthetic peptide derivative belonging to the bradykinin family, characterized by the absence of the C-terminal arginine residue at position nine. As a biologically active peptide fragment, it serves as a selective agonist or antagonist for bradykinin receptor subtypes, particularly the B1 receptor, distinguishing itself from the parent bradykinin molecule, which primarily interacts with B2 receptors. Its structure and receptor specificity make it a valuable tool in the study of kinin-mediated signaling pathways, inflammation, and vascular biology. Researchers utilize this compound to dissect the physiological and pathophysiological roles of bradykinin receptor subtypes in diverse experimental systems, advancing understanding of peptide-receptor interactions and downstream cellular responses.

Receptor Pharmacology: [Des-Arg9]-Bradykinin acetate is extensively applied in investigations of bradykinin receptor pharmacology, particularly for characterizing the B1 receptor. By selectively activating or blocking B1 receptors in cell-based assays or tissue preparations, scientists can delineate the distinct signaling cascades and functional consequences associated with B1 versus B2 receptor engagement. Such studies are instrumental in mapping receptor distribution, understanding ligand selectivity, and elucidating the molecular mechanisms underlying kinin-mediated responses in inflammation, pain, and vascular modulation.

Inflammation and Immune Response Research: The peptide is widely used to model and analyze inflammatory processes at the cellular and tissue levels. Its ability to selectively engage B1 receptors, which are typically upregulated during tissue injury or inflammation, enables researchers to investigate the regulation and functional outcomes of B1 receptor activation. Experimental systems employing [Des-Arg9]-Bradykinin acetate help uncover the roles of kinins in leukocyte recruitment, cytokine production, and endothelial cell activation, providing insights into the molecular underpinnings of inflammatory diseases.

Signal Transduction Studies: As a receptor-specific ligand, [Des-Arg9]-Bradykinin acetate facilitates detailed exploration of intracellular signaling mechanisms initiated by B1 receptor activation. Researchers employ the peptide to stimulate defined signaling pathways, such as phospholipase activation, calcium mobilization, and MAP kinase cascades, in various cellular models. These studies are critical for identifying downstream effectors, cross-talk with other signaling networks, and potential points of pharmacological intervention within kinin-related pathways.

Vascular Biology and Permeability Assays: The compound is frequently utilized in vascular research to assess the functional impact of B1 receptor activation on blood vessel tone, permeability, and endothelial barrier function. By applying [Des-Arg9]-Bradykinin acetate to isolated vessel preparations or endothelial cell cultures, investigators can quantify changes in vascular reactivity, permeability, and inflammatory mediator release. These assays contribute to a deeper understanding of how kinins modulate vascular homeostasis and participate in pathophysiological conditions such as edema or hypertension.

Peptide-Receptor Binding and Structure-Activity Relationship Analysis: [Des-Arg9]-Bradykinin acetate serves as a reference ligand in binding assays and structure-activity relationship (SAR) studies involving bradykinin receptors. Its defined structure and receptor selectivity make it a benchmark for comparing the affinity and efficacy of novel peptide analogs or small-molecule modulators targeting kinin receptors. Such applications are essential for advancing drug discovery efforts, optimizing ligand design, and refining models of peptide-receptor interaction at the molecular level.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef